文献速递心力衰竭与心肌病心律失常

遗传性心血管疾病基因检测的临床效果:14年回顾性研究

Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study.
PubMed 文献 · J Am Coll Cardiol · 2025-01-01

该研究纳入蒙特利尔心脏研究所遗传性心肌病或心律失常连续先证者2062例,评估基因检测的临床效用。结果显示24%的先证者检出致病/可能致病变异,8%的基因检测结果对临床管理有潜在影响;对比本地人群队列的等位基因频率数据可优化变异解读与分类。

要点

  • 在临床背景下,遗传性心肌病或心律失常先证者中基因检测的致病/可能致病变异检出率为24%。
  • 基因检测结果对8%的先证者具有诊断细化作用并可能影响临床管理。
  • 利用本地人群等位基因频率数据可优化变异解读与分类,研究中有9个变异因病例对照富集比较而改变分类。

核心结论

  • 在临床背景下,基因检测在24%的先证者中识别出致病/可能致病变异,凸显罕见变异基因检测的高产出。
  • 除家族筛查外,基因检测结果还影响临床管理。
  • 获取本地人群的等位基因频率数据可优化变异解读与分类。

研究设计与样本

  • 研究为14年回顾性研究,纳入蒙特利尔心脏研究所心血管遗传中心连续先证者,纳入标准为疑似遗传性心肌病或心律失常且临床数据与基因检测结果均可获得。
  • 共纳入2062例先证者,诊断时平均年龄47±17岁。
  • 研究通过比较病例队列与本地人群队列中复发性罕见遗传变异的患病率,分析其富集情况。

主要发现

  • 总体而言,基因检测在496例(24%)先证者中识别出致病/可能致病(P/LP)变异。
  • 在利用本地人群队列比较患病率(病例对照富集)后,共有9个变异的分类发生改变。
  • 基因检测使168例(8%)先证者获得诊断细化,并可能影响临床管理。

临床怎么用

  • 对疑似遗传性心肌病或心律失常的先证者,基因检测可提供较高的致病/可能致病变异检出率。
  • 基因检测结果不仅用于家族筛查,还可细化诊断并可能影响临床管理决策。
  • 在变异解读中,参考本地人群等位基因频率数据有助于优化分类,减少误判。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical impact of genetic testing in a contemporary real-life cohort of patients with heritable cardiomyopathies or arrhythmias is not well defined. Additionally, the genetic spectrum of these conditions in the French-Canadian population is unknown, and interpretation of genetic variants can be challenging because of a known founder effect. OBJECTIVES: This study sought to evaluate the clinical utility of arrhythmia and cardiomyopathy genetic testing and assess the utility of allele frequency data from a local reference population. METHODS: The study included consecutive probands seen at the Montreal Heart Institute Cardiovascular Genetics Centre (Montreal, Quebec, Canada) for suspected heritable cardiomyopathies or arrhythmias for which both clinical data and genetic testing results were available. The study analyzed the enrichment of recurrent rare genetic variants by comparing their prevalence in the case cohort with that of a local population cohort. RESULTS: A total of 2,062 probands (mean age at diagnosis 47 ± 17 years) were included. Overall, genetic testing identified a pathogenic/likely pathogenic (P/LP) variant in 496 (24%) probands. A total of 9 variants had their classification changed after comparing their prevalence (case control enrichment) using a local population-based cohort. Genetic testing resulted in diagnostic refinement with a potential impact on clinical management in 168 (8%) probands. CONCLUSIONS: Genetic testing in a clinical context identified a disease-causing variant in 24% of probands, thus highlighting the high yield of rare variant genetic testing. Beyond the impact on family screening, the genetic testing result affected clinical management. Access to allele frequency data from a local population refines variant interpretation and classification.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Grondin S, Neveu B, Soltani I, et al. Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study. J Am Coll Cardiol. 2025. PMID: 40074473. doi:10.1016/j.jacc.2024.11.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。